NOTCH1 mutations identify a chronic lymphocytic leukemia patient subset with worse prognosis in the setting of a rituximab-based induction and consolidation treatment

Michele Dal Bo, Maria Ilaria Del Principe, Federico Pozzo, Dario Ragusa, Pietro Bulian, Davide Rossi, Giovanni Capelli, Francesca Maria Rossi, Pasquale Niscola, Francesco Buccisano, Riccardo Bomben, Antonella Zucchetto, Luca Maurillo, Paolo de Fabritiis, Sergio Amadori, Gianluca Gaidano, Valter Gattei, Giovanni Del Poeta

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'NOTCH1 mutations identify a chronic lymphocytic leukemia patient subset with worse prognosis in the setting of a rituximab-based induction and consolidation treatment'. Together they form a unique fingerprint.

Medicine & Life Sciences